Zota Health Care (NSE:ZOTA) ROCE %: -9.44% (As of Mar. 2026)


NSE:ZOTA Zota Health Care Ltd NSE:ZOTA
77 GF Score
Price ₹1,389.50
GF Value ₹1,568.77
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zota Health Care ROCE %?

Zota Health Care NSE:ZOTA +0.35% 77 ROCE % is -9.44% as of Mar. 2026. GuruFocus rates NSE:ZOTA with a GF Score™ of 77/100 and a GF Value™ of ₹1,568.77 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zota Health Care's annualized ROCE % for the quarter that ended in Mar. 2026 was -9.44%.

Zota Health Care  (NSE:ZOTA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zota Health Care ROCE % Related Terms

Zota Health Care ROCE % Historical Data

* Premium members only.

The historical data trend for Zota Health Care's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zota Health Care ROCE % Chart

Zota Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.90 -2.00 -8.79 -19.00 -10.14

Zota Health Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.82 -11.63 -9.14 -18.17 -9.44
NSE:ZOTA
77GF Score
Zota Health Care Ltd NSE:ZOTA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zota Health Care ROCE % Calculation

Zota Health Care's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=-624.756/( ( (4391.405 - 1006.138) + (11310.514 - 2372.728) )/ 2 )
=-624.756/( (3385.267+8937.786)/ 2 )
=-624.756/6161.5265
=-10.14 %

Zota Health Care's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-843.972/( ( (0 - 0) + (11310.514 - 2372.728) )/ 1 )
=-843.972/( ( 0 + 8937.786 )/ 1 )
=-843.972/8937.786
=-9.44 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -9.44% mean?
Zota Health Care (NSE:ZOTA) has a ROCE % of -9.44% as of Mar. 2026.
Is Zota Health Care's ROCE % too high?
Zota Health Care's current ROCE % is -9.44%. Overall, Zota Health Care has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's ROCE % compare to VRTX and REGN?
Zota Health Care's ROCE % of -9.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Zota Health Care's current ROCE % is -9.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,568.77, compared to a current price of ₹1,389.50 — trading 11.4% below its estimated fair value. The current ROCE % is -9.44%. Zota Health Care's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current ROCE % is -9.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?

Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued. The current stock price of ₹1,389.50 is trading 11.4% below its estimated GF Value™ of ₹1,568.77. GuruFocus considers Zota Health Care to be Modestly Undervalued.

Key valuation signals for NSE:ZOTA:

  • ROCE %: -9.44%
  • GF Value™: ₹1,568.77 vs. price of ₹1,389.50 (11.4% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zota Health Care Business Description

Address 2/896, Hira Modi Street, Zota House, Sagrampura, Surat, GJ, IND, 395002
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
77GF Score

Get the complete analysis for NSE:ZOTA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,389.50
Price
₹1,568.77
GF Value